Gu Yingchun, Song Yelin, Liu Yufeng
Department of Respiratory Medicine, Qingdao Chest Hospital & Cardiovascular Medicine, Qingdao 266043, China.
Email:
Zhonghua Yi Xue Za Zhi. 2014 Sep 30;94(36):2838-40.
To explore the clinical characteristics and prognostic factors of pulmonary tuberculosis with concurrent lung cancer.
Comprehensive analyses were conducted for 58 cases of pulmonary tuberculosis patients with lung cancer. Their clinical symptoms, signs and imaging results were analyzed between January 1998 and January 2005 at Qingdao Chest Hospital. Kaplan-Meier method was utilized to calculate their survival rates. Nine prognostic characteristics were analyzed. Single factor analysis was performed with Logrank test and multi-factor analysis with Cox regression model.
The initial symptoms were cough, chest tightness, fever and hemoptysis. Chest radiology showed the coexistence of two diseases was 36 in the same lobe and 22 in different lobes. And there were pulmonary nodules (n = 24), cavities (n = 19), infiltration (n = 8) and atelectasis (n = 7). According to the pathological characteristics, there were squamous carcinoma (n = 33), adenocarcinoma (n = 17), small cell carcinoma (n = 4) and unidentified (n = 4) respectively. The TNM stages were I (n = 13), II(n = 22), III (n = 16) and IV (n = 7) respectively. The median survival period was 24 months. And the 1, 3, 5-year survival rates were 65.5%, 65.5% and 29.0% respectively. Single factor analysis showed that lung cancer TNM staging (P = 0.000) and tuberculosis activity (P = 0.024) were significantly associated with patient prognosis. And multi-factor analysis showed that lung cancer TNM staging (RR = 2.629, 95%CI: 1.759-3.928, P = 0.000) and tuberculosis activity (RR = 1.885, 95%CI: 1.023-3.471, P = 0.042) were relatively independent prognostic factors.
The clinical and radiological characteristics contribute jointly to early diagnosis and therapy of tuberculosis with concurrent lung cancer. And TNM staging of lung cancer and activity of tuberculosis are major prognostic factors.
探讨合并肺癌的肺结核的临床特征及预后因素。
对58例合并肺癌的肺结核患者进行综合分析。分析了1998年1月至2005年1月在青岛市胸科医院就诊的患者的临床症状、体征及影像学检查结果。采用Kaplan-Meier法计算生存率。分析了9项预后特征。采用Logrank检验进行单因素分析,采用Cox回归模型进行多因素分析。
首发症状为咳嗽、胸闷、发热和咯血。胸部影像学检查显示,两种疾病并存于同一肺叶36例,不同肺叶22例。有肺结节(n = 24)、空洞(n = 19)、浸润(n = 8)和肺不张(n = 7)。根据病理特征,分别有鳞癌(n = 33)、腺癌(n = 17)、小细胞癌(n = 4)和未明确类型(n = 4)。TNM分期分别为Ⅰ期(n = 13)、Ⅱ期(n = 22)、Ⅲ期(n = 16)和Ⅳ期(n = 7)。中位生存期为24个月。1年、3年、5年生存率分别为65.5%、65.5%和29.0%。单因素分析显示,肺癌TNM分期(P = 0.000)和肺结核活动度(P = 0.024)与患者预后显著相关。多因素分析显示,肺癌TNM分期(RR = 2.629,95%CI:1.759 - 3.928,P = 0.000)和肺结核活动度(RR = 1.885,95%CI:1.023 - 3.471,P = 0.042)是相对独立的预后因素。
临床及影像学特征共同有助于合并肺癌的肺结核的早期诊断与治疗。肺癌TNM分期及肺结核活动度是主要的预后因素。